Search

43 Result(s)
Sort by

Advances in vectored vaccines for poultry

Advances in vectored vaccines for poultry

Click here to learn how vaccine design technologies have made huge advances in recent years to overcome challenges that conventional vaccines do not meet.
Production Insights

Production Insights

Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.
Transboundary and emerging diseases

Transboundary and emerging diseases

We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
Stem cells a new frontier

Stem cells a new frontier

Stem cells may be a game changer for the development of new veterinary treatments. Click here to read this story and find out more information.
From Idea to Drug

From Idea to Drug

Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
Accessibility Statement

Accessibility Statement

Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible.
More Cherished Moments

More Cherished Moments

Innovation in healthcare is about more than just a new approach or technology. We innovate for better health of people and animals. Learn more here.
Poultry Innovation Days 2018

Poultry Innovation Days 2018

As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
Fremont

Fremont

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Fremont site.
Xochimilco

Xochimilco

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Xochimilco site.
Sant Cugat del Vallès

Sant Cugat del Vallès

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Shanghai site.
Vienna

Vienna

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Vienna site.
The Nagoya Protocol

The Nagoya Protocol

At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do. Read our commitments to the Nagoya Protocol.
COVID-19 Protecting Our Employees

COVID-19 Protecting Our Employees

We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
Ridgefield

Ridgefield

Learn more about Ridgefield, the home of Boehringer Ingelheim's US headquarters. The site serves as a key research centre for human pharmaceuticals.
Women in STEM 2022

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Kobe

Kobe

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Kobe site.
Our Partnering Culture

Our Partnering Culture

We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture.
Resizing our Carbon Footprint

Resizing our Carbon Footprint

The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.